| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 153.81B | 155.63B | 134.43B | 159.46B | 142.20B | 106.72B |
| Gross Profit | 44.82B | 44.16B | 37.04B | 45.48B | 40.09B | 28.04B |
| EBITDA | 25.06B | 25.60B | 19.94B | 27.82B | 23.79B | 13.21B |
| Net Income | 12.94B | 13.52B | 8.34B | 14.79B | 12.57B | 5.27B |
Balance Sheet | ||||||
| Total Assets | 210.26B | 210.87B | 208.28B | 185.63B | 172.51B | 152.73B |
| Cash, Cash Equivalents and Short-Term Investments | 35.35B | 35.33B | 28.30B | 28.57B | 34.53B | 36.38B |
| Total Debt | 34.32B | 35.80B | 37.53B | 18.63B | 17.89B | 20.41B |
| Total Liabilities | 73.28B | 74.34B | 79.18B | 65.89B | 62.94B | 55.10B |
| Stockholders Equity | 136.98B | 136.52B | 129.10B | 119.73B | 109.57B | 97.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.47B | -12.26B | -7.00M | 4.47B | 14.79B |
| Operating Cash Flow | 0.00 | 19.17B | 7.60B | 11.05B | 12.35B | 17.52B |
| Investing Cash Flow | 0.00 | -6.06B | -20.23B | -12.79B | -8.54B | -2.79B |
| Financing Cash Flow | 0.00 | -6.18B | 13.05B | -5.74B | -6.26B | 2.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥277.44B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
75 Outperform | ¥64.75B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
73 Outperform | ¥261.07B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥475.50B | 26.32 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥368.21B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥514.96B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |